Wnt signaling: a key regulator of bone mass
- PMID: 17118265
- DOI: 10.1016/S0070-2153(06)76004-5
Wnt signaling: a key regulator of bone mass
Abstract
The identification of a link between bone mass in humans and gain- [high bone mass (HBM) trait] or loss-of-function [osteoporosis pseudoglioma (OPPG) syndrome] mutations in the Wnt coreceptor lipoprotein receptor-related protein (LRP)5 or in the Wnt antagonist sclerostin (sclerosteosis, Van Buchem syndrome) has called the attention of academic and industry scientists and clinicians to the importance of this signaling pathway in skeletal biology and disease. Multiple genetic and pharmacological manipulations of Wnt signaling in mice have since then confirmed the central role of this pathway in both the establishment of peak bone mass and its maintenance throughout life. Wnt signaling appears to be located downstream of bone morphogenetic proteins (BMPs), itself induced by Hedgehog (Hh) signaling, suggesting that it is the successive recruitment of these three intracellular signaling cascades that allow the full expression of the genetic patterns that characterize the osteoblast, the cell responsible for the formation of bone.
Similar articles
-
[Wnt-beta-catenin signaling in bone metabolism].Clin Calcium. 2006 Jan;16(1):54-60. Clin Calcium. 2006. PMID: 16397351 Review. Japanese.
-
Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27. Bone. 2008. PMID: 18294945
-
Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.Endocrinology. 2007 Jun;148(6):2635-43. doi: 10.1210/en.2007-0270. Epub 2007 Mar 29. Endocrinology. 2007. PMID: 17395698 Review.
-
The Wnt signaling pathway and bone metabolism.Curr Opin Rheumatol. 2007 Jul;19(4):376-82. doi: 10.1097/BOR.0b013e32816e06f9. Curr Opin Rheumatol. 2007. PMID: 17551370 Review.
-
Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.J Bone Miner Res. 2009 Oct;24(10):1651-61. doi: 10.1359/jbmr.090411. J Bone Miner Res. 2009. PMID: 19419300
Cited by
-
Euodia sutchuenensis Dode extract stimulates osteoblast differentiation via Wnt/β-catenin pathway activation.Exp Mol Med. 2015 Mar 20;47(3):e152. doi: 10.1038/emm.2014.115. Exp Mol Med. 2015. PMID: 25792220 Free PMC article.
-
Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo.J Biol Chem. 2010 Dec 17;285(51):40135-47. doi: 10.1074/jbc.M110.166892. Epub 2010 Oct 7. J Biol Chem. 2010. PMID: 20929859 Free PMC article.
-
CD73-generated adenosine promotes osteoblast differentiation.J Cell Physiol. 2012 Jun;227(6):2622-31. doi: 10.1002/jcp.23001. J Cell Physiol. 2012. PMID: 21882189 Free PMC article.
-
Leucine-rich amelogenin peptide induces osteogenesis by activation of the Wnt pathway.Biochem Biophys Res Commun. 2009 Sep 25;387(3):558-63. doi: 10.1016/j.bbrc.2009.07.058. Epub 2009 Jul 16. Biochem Biophys Res Commun. 2009. PMID: 19615979 Free PMC article.
-
Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin.J Cell Biol. 2013 Feb 18;200(4):537-49. doi: 10.1083/jcb.201207142. Epub 2013 Feb 11. J Cell Biol. 2013. PMID: 23401003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous